<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pneumonia in children: Epidemiology, pathogenesis, and etiology</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pneumonia in children: Epidemiology, pathogenesis, and etiology</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pneumonia in children: Epidemiology, pathogenesis, and etiology</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William J Barson, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 14, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Childhood pneumonia is an important cause of morbidity in resource-rich countries, and morbidity and mortality in resource-limited countries. The epidemiology, microbiology, and pathogenesis of pneumonia in children will be reviewed here. The clinical features, diagnosis, and treatment of pneumonia in children and pneumonia in neonates (&lt;28 days) are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5986.html" rel="external">"Community-acquired pneumonia in children: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5987.html" rel="external">"Community-acquired pneumonia in children: Outpatient treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6054.html" rel="external">"Pneumonia in children: Inpatient treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5004.html" rel="external">"Neonatal pneumonia"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>The terms pneumonia and pneumonitis strictly represent any inflammatory condition involving the lungs, which include the visceral pleura, connective tissue, airways, alveoli, and vascular structures.</p><p>Lower respiratory tract infection (LRTI) is frequently used interchangeably to include bronchitis, bronchiolitis, and pneumonia, or any combination of the three.</p><p>For this review, pneumonia will be defined as a condition typically associated with fever, respiratory symptoms, and evidence of parenchymal involvement, either by physical examination or the presence of infiltrates on chest radiography.</p><p>Bronchiolitis is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6018.html" rel="external">"Bronchiolitis in infants and children: Clinical features and diagnosis", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H4"><span class="h2">Incidence and hospitalization</span><span class="headingEndMark"> — </span>The incidence of childhood pneumonia varies geographically.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Resource-rich countries</strong> – In resource-rich countries, the annual incidence of pneumonia is estimated to be 3.3 per 1000 in children younger than 5 years and 1.45 per 1000 in children 0 to 16 years [<a href="#rid1">1</a>]. Approximately one-half of children younger than five years of age with community-acquired pneumonia require hospitalization [<a href="#rid2">2</a>]. Hospitalization rates for pneumonia (all causes) among children younger than two years in the United States decreased after introduction of the pneumococcal conjugate vaccine (PCV) to the routine childhood immunization schedule in 2000 (from 12 to 14 per 1000 population to 8 to 10 per 1000 population between 1997 and 2006)  (<a class="graphic graphic_figure graphicRef52194" href="/z/d/graphic/52194.html" rel="external">figure 1</a>) [<a href="#rid3">3</a>]. After licensure of 13-valent PCV in 2010, hospitalization rates for pneumonia (all causes) among children younger than two years in a single state declined to 4 per 1000, compared with 14 to 15 per 1000 before licensure of the 7-valent PCV (PCV7) and 8 to 9 per 1000 in the PCV7 years [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Resource-limited countries</strong> – In a systematic review, the annual incidence of pneumonia in children younger than five years from resource-limited countries in 2015 was estimated to be 231 per 1000; 50 to 80 percent of children with severe pneumonia required hospitalization [<a href="#rid2">2</a>]. </p><p></p><p class="headingAnchor" id="H5"><span class="h2">Mortality</span><span class="headingEndMark"> — </span>In 2015, lower respiratory tract infections (LRTIs) accounted for nearly 800,000 deaths among children ≤19 years worldwide (31.1 per 100,000 population), second only to neonatal/preterm birth complications [<a href="#rid5">5</a>]. In observational studies in resource-rich countries, the case fatality rate among hospitalized children &lt;5 years of age was &lt;1 percent [<a href="#rid2">2,6</a>]. In a systematic review, the case fatality rate among hospitalized children &lt;5 years in resource-limited countries ranged from 0.3 to 15 percent [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Seasonality</span><span class="headingEndMark"> — </span>Although both viral and bacterial pneumonia occur throughout the year, they are more prevalent during the colder months. The mechanisms responsible for this observed seasonality are likely multifactorial including environmental factors (eg, temperature, absolute humidity, sunlight) affecting both the pathogen (virus stability and transmissibility) as well as the host (eg, local, innate, and adaptive immune function) and human behavior patterns (indoor crowding during the winter months enhancing direct transmission of infected droplets) [<a href="#rid7">7</a>]. For reasons that are unknown, different viruses cause peaks of infection at different times during the respiratory virus season, and these peaks seldom occur simultaneously [<a href="#rid8">8</a>]. In tropical regions, peaks of infection follow no common pattern and can occur during either the wet or dry seasons.</p><p class="headingAnchor" id="H7"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Lower socioeconomic groups have a higher prevalence of LRTIs, which correlates best with family size, a reflection of environmental crowding. School-age children often introduce respiratory viral agents into households, resulting in secondary infections in their caregivers and siblings [<a href="#rid8">8</a>].</p><p>Underlying cardiopulmonary disorders and other medical conditions predispose to pneumonia and contribute to increasing severity. These include [<a href="#rid9">9,10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Congenital heart disease</p><p class="bulletIndent1"><span class="glyph">●</span>Bronchopulmonary dysplasia</p><p class="bulletIndent1"><span class="glyph">●</span>Cystic fibrosis</p><p class="bulletIndent1"><span class="glyph">●</span>Asthma</p><p class="bulletIndent1"><span class="glyph">●</span>Sickle cell disease</p><p class="bulletIndent1"><span class="glyph">●</span>Neuromuscular disorders, especially those associated with a depressed consciousness</p><p class="bulletIndent1"><span class="glyph">●</span>Some gastrointestinal disorders (eg, gastroesophageal reflux, tracheoesophageal fistula)</p><p class="bulletIndent1"><span class="glyph">●</span>Congenital and acquired immunodeficiency disorders</p><p></p><p>Cigarette smoke compromises natural pulmonary defense mechanisms by disrupting both mucociliary function and macrophage activity [<a href="#rid11">11</a>]. Exposure to cigarette smoke, especially if the mother smokes, increases the risk for pneumonia in infants younger than one year of age. (See  <a class="medical medical_review" href="/z/d/html/6375.html" rel="external">"Secondhand smoke exposure: Effects in children"</a>.)</p><p>The use of cigarettes, alcohol, and other substances of abuse in adolescents may increase the risk of pneumonia by increasing the risk of aspiration through impairment of the cough and epiglottic reflexes. In addition, the use of alcohol has been associated with increased colonization of the oropharynx with aerobic gram-negative bacilli [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Effect of vaccines</span><span class="headingEndMark"> — </span>Immunization with the <em>Haemophilus</em> <em>influenzae</em> type b (Hib) and pneumococcal conjugate vaccines protects children from invasive disease caused by these organisms. Hib was once a common cause of pneumonia in young children in the United States. However, it has been virtually eliminated as a result of routine immunization with Hib conjugate vaccines. (See  <a class="medical medical_review" href="/z/d/html/6022.html" rel="external">"Prevention of <i>Haemophilus influenzae</i> type b infection", section on 'Efficacy/effectiveness'</a>.)</p><p>The universal immunization of infants in the United States and other countries with the PCV has effectively decreased the incidence of pneumonia requiring hospitalization and other invasive <em>Streptococcus</em> <em>pneumoniae</em> infections in children [<a href="#rid4">4,13-17</a>]. (See  <a class="medical medical_review" href="/z/d/html/6053.html" rel="external">"Pneumococcal vaccination in children", section on 'Efficacy and effectiveness'</a>.)</p><p>Pneumococcal vaccination also reduces the risk of viral pneumonia. In a randomized trial, complete immunization with a 9-valent pneumococcal conjugate vaccine was associated with a 31 percent reduction (95% CI 15-43) in the incidence of pneumonia associated with any of seven respiratory viruses (influenza A/B, parainfluenza types 1 to 3, respiratory syncytial virus, adenovirus) in hospitalized children [<a href="#rid18">18</a>]. This observation suggests that the pneumonias associated with these viruses in hospitalized children are often because of concurrent pneumococcal infection.</p><p class="headingAnchor" id="H9"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Pneumonia occurs because of an impairment of host defenses, invasion by a virulent organism, and/or invasion by an overwhelming inoculum.</p><p>In the typical scenario, pneumonia follows an upper respiratory tract illness that permits invasion of the lower respiratory tract by bacteria, viruses, or other pathogens that trigger the immune response and produce inflammation [<a href="#rid19">19,20</a>]. The lower respiratory tract air spaces fill with white blood cells, fluid, and cellular debris. This process reduces lung compliance, increases resistance, obstructs smaller airways, and may result in collapse of distal air spaces, air trapping, and altered ventilation-perfusion relationships [<a href="#rid19">19</a>]. Severe infection is associated with necrosis of bronchial or bronchiolar epithelium [<a href="#rid21">21</a>] and/or pulmonary parenchyma [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Acquisition</span><span class="headingEndMark"> — </span>The agents that cause lower respiratory tract infection are most often transmitted by droplet spread resulting from close contact with a source case. Contact with contaminated fomites also may be important in the acquisition of viral agents, especially respiratory syncytial virus.</p><p>Most typical bacterial pneumonias (eg, <em>S</em>. <em>pneumoniae</em>) are the result of initial colonization of the nasopharynx followed by aspiration or inhalation of organisms. Invasive disease most commonly occurs upon acquisition of a new serotype of the organism with which the patient has not had previous experience, typically after an incubation period of one to three days. Occasionally, a primary bacteremia may precede the pneumonia. Atypical bacterial pathogens (eg, <em>Mycoplasma</em> <em>pneumoniae</em>, <em>Chlamydia</em> <em>pneumoniae)</em> attach to respiratory epithelial membranes through which they enter cells for replication.</p><p>The viral agents that cause pneumonia proliferate and spread by contiguity to involve lower and more distal portions of the respiratory tract.</p><p class="headingAnchor" id="H11"><span class="h2">Normal host defense</span><span class="headingEndMark"> — </span>The pulmonary host defense system is complex and includes anatomic and mechanical barriers, humoral immunity, phagocytic activity, and cell-mediated immunity [<a href="#rid23">23,24</a>], as discussed below, with a focus on bacterial infection. The host response to respiratory viral infection is beyond the scope of this review; more information can be obtained from the reference [<a href="#rid25">25</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Anatomic and mechanical barriers – Anatomic and mechanical barriers in the upper airway form an important part of the host defense. Particles greater than 10 microns are efficiently filtered by the hairs in the anterior nares or are trapped on mucosal surfaces. The nasal mucosa contains ciliated epithelium and mucus-producing cells. The cilia beat synchronously, clearing the entrapped organisms through the nasopharynx via expulsion or swallowing. In the oropharynx, salivary flow, sloughing of epithelial cells, local production of complement and immunoglobulin (Ig)A, and bacterial interference from the resident flora serve as important factors in local host defense.</p><p></p><p class="bulletIndent1">An intact epiglottic reflex helps to prevent aspiration of infected secretions, and the cough reflex helps to expel materials that may be aspirated. The sharp angles at which the central airways branch cause 5 to 10 micron particles to impact on mucosal surfaces, where they are entrapped in endobronchial mucus. Once entrapped, the ciliary system moves the particles upward out of the airways into the throat, where they are normally swallowed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Humoral immunity – Secretory IgA is the major immunoglobulin produced in the upper airways and accounts for 10 percent of the total protein concentration of nasal secretions. Although it is not a very good opsonizing agent, it does possess antibacterial and antiviral activity. IgG and IgM enter the airways and alveolar spaces predominantly via transudation from the blood and act to opsonize bacteria, activate complement, and neutralize toxin. Immunoglobulins, surfactant, fibronectin, and complement act as effective opsonins to help eliminate microorganisms (0.5 to 1 micron particles) that reach the terminal airways and alveoli. Free fatty acids, lysozyme, and iron-binding proteins also are present and may be microbicidal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Phagocytic cells – There are two populations of phagocytic cells in the lung: polymorphonuclear leukocytes from the blood and macrophages. There are several distinct populations of macrophages, which vary in their location and function:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The alveolar macrophage is located in the alveolar fluid and is the first phagocyte encountered by inert particles and potential pathogens entering the lung. If this cell is overwhelmed, it has the capacity to become a mediator of inflammation and produce cytokines that recruit neutrophils.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Interstitial macrophages are located in the lung connective tissue and serve both as phagocytic cells and antigen-processing cells.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The intravascular macrophage is located in capillary endothelial cells and phagocytizes and removes foreign material entering the lungs via the bloodstream.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cell-mediated immunity – Cell-mediated immunity is especially important against certain pathogens, including viruses and intracellular microorganisms that can survive within pulmonary macrophages. Although relatively few in number (5 to 10 percent of the total lung parenchyma cell population), lymphocytes play three critical roles: the production of antibody, cytotoxic activity, and the production of cytokines.</p><p></p><p class="headingAnchor" id="H12"><span class="h2">Pathologic patterns of pneumonia</span><span class="headingEndMark"> — </span>There are five pathologic patterns of bacterial pneumonia [<a href="#rid20">20</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Lobar pneumonia – Involvement of a single lobe or segment of a lobe. This is the classic pattern of <em>S</em>. <em>pneumoniae</em> pneumonia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bronchopneumonia – Primary involvement of airways and surrounding interstitium. This pattern is sometimes seen in <em>Streptococcus</em> <em>pyogenes</em> and <em>Staphylococcus</em> <em>aureus</em> pneumonia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Necrotizing pneumonia (associated with aspiration pneumonia and pneumonia resulting from <em>S</em>. <em>pneumoniae</em>  (<a class="graphic graphic_diagnosticimage graphicRef86362" href="/z/d/graphic/86362.html" rel="external">image 1</a>), <em>S</em>. <em>pyogenes</em>, and <em>S</em>. <em>aureus</em>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Caseating granuloma (as in pneumonia caused by <em>Mycobacterium</em> <em>tuberculosis</em> and the endemic mycoses).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Interstitial and peribronchiolar with secondary parenchymal infiltration – This pattern typically occurs when a severe viral pneumonia is complicated by bacterial pneumonia.</p><p></p><p>There are two major pathologic patterns of viral pneumonia [<a href="#rid20">20</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Interstitial pneumonia  (<a class="graphic graphic_diagnosticimage graphicRef82288" href="/z/d/graphic/82288.html" rel="external">image 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Parenchymal infection.</p><p></p><p class="headingAnchor" id="H14"><span class="h1">ETIOLOGIC AGENTS</span><span class="headingEndMark"> — </span>A large number of microorganisms have been implicated as etiologic agents of pneumonia in children  (<a class="graphic graphic_table graphicRef54228 graphicRef71263" href="/z/d/graphic/54228.html" rel="external">table 1A-B</a>). The agents commonly responsible vary according to the age of the child and the setting in which the infection is acquired.</p><p class="headingAnchor" id="H15"><span class="h2">Community-acquired pneumonia</span><span class="headingEndMark"> — </span>Community-acquired pneumonia (CAP) is an acute infection of the pulmonary parenchyma that is acquired in the community. The true prevalence of the various etiologic agents in CAP in children is difficult to determine. Studies investigating the etiology of childhood pneumonia have been performed in populations of various ages, in various settings, and using a variety of microbiologic techniques [<a href="#rid6">6,26-37</a>]. Because direct culture of infected lung tissue requires invasive techniques, published studies primarily use laboratory tests that provide indirect evidence of etiology (eg, nasopharyngeal culture, blood culture, polymerase chain reaction (PCR), serology). Interpretation of the results is further hampered by the failure to identify an organism in 15 to 35 percent of cases and the frequency of mixed infections (in 23 to 33 percent of cases) [<a href="#rid1">1,6,38</a>]. </p><p>The most common causes of CAP in children vary with age.</p><p class="headingAnchor" id="H17"><span class="h3">In neonates</span><span class="headingEndMark"> — </span>The etiology of pneumonia in neonates (infants &lt;28 days of age) is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5004.html" rel="external">"Neonatal pneumonia", section on 'Etiology'</a>.)</p><p class="headingAnchor" id="H18"><span class="h3">In infants</span><span class="headingEndMark"> — </span>Viruses are the most common cause of CAP in infants younger than one year. They account for &gt;80 percent of CAP in children younger than two years [<a href="#rid6">6</a>]. Infants may also develop "afebrile pneumonia of infancy," a syndrome that typically occurs between two weeks and three to four months of age. It is classically caused by <em>Chlamydia</em> <em>trachomatis</em>, but other agents, such as cytomegalovirus (CMV), <em>Mycoplasma</em> <em>hominis</em>, and <em>Ureaplasma</em> <em>urealyticum</em>, also are implicated. (See  <a class="medical medical_review" href="/z/d/html/4993.html" rel="external">"Chlamydia trachomatis infections in the newborn", section on 'Pneumonia'</a>.)</p><p>Infants with severe <em>Bordetella</em> <em>pertussis</em> infection also may develop pneumonia. (See  <a class="medical medical_review" href="/z/d/html/5995.html" rel="external">"Pertussis infection in infants and children: Clinical features and diagnosis", section on 'Complications'</a>.)</p><p class="headingAnchor" id="H3015326395"><span class="h3">In children &lt;5 years</span></p><p class="bulletIndent1"><span class="glyph">●</span>Viruses – Viruses are the most common etiology of CAP in older infants and children younger than five years of age [<a href="#rid1">1,6,39</a>]. They account for up to 50 percent of cases in young children [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">Respiratory syncytial virus (RSV), a member of the <em>Pneumoviridae</em> virus family [<a href="#rid40">40</a>], is the most common viral pathogen responsible for pneumonia in children younger than five years [<a href="#rid6">6,32,39,41,42</a>]. RSV pneumonia frequently represents an extension of bronchiolitis. (See  <a class="medical medical_review" href="/z/d/html/6018.html" rel="external">"Bronchiolitis in infants and children: Clinical features and diagnosis", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/z/d/html/5994.html" rel="external">"Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent1">Other viral causes of pneumonia in children younger than five years, in decreasing order of likelihood, include [<a href="#rid6">6,42</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Influenza A and B viruses.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Human metapneumovirus is a common cause of lower respiratory tract infections (LRTIs) in children; most children have been infected by five years of age. (See  <a class="medical medical_review" href="/z/d/html/8311.html" rel="external">"Human metapneumovirus infections"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A number of adenovirus serotypes (eg, 1, 2, 3, 4, 5, 7, 14, 21, and 35) have been reported to cause pneumonia; serotypes 3, 7, and 21 have been associated with severe and complicated pneumonia [<a href="#rid43">43</a>]. Adenovirus was found to be strongly associated with CAP in children younger than two years [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/8339.html" rel="external">"Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection", section on 'Clinical presentation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Parainfluenza viruses, usually type 3. (See  <a class="medical medical_review" href="/z/d/html/5975.html" rel="external">"Parainfluenza viruses in children", section on 'Clinical presentation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Enterovirus D68 emerged as a significant pathogen of lower respiratory tract disease among American children in 2014 [<a href="#rid44">44,45</a>]. (See  <a class="medical medical_review" href="/z/d/html/2694.html" rel="external">"Enterovirus and parechovirus infections: Epidemiology and pathogenesis", section on 'Periodicity and variability of disease by serotype'</a> and  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Respiratory disease'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Coronaviruses (229E, OC43, NL63, HKU1) as well as SARS-CoV (responsible for severe acute respiratory syndrome), MERS-CoV (responsible for Middle East respiratory syndrome), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; responsible for coronavirus disease-2019 [COVID-19]) may also cause respiratory tract infections in children younger than five years [<a href="#rid46">46-48</a>]. However, their clinical impact has yet to be fully determined [<a href="#rid41">41,42,49</a>]. (See  <a class="medical medical_review" href="/z/d/html/8298.html" rel="external">"Coronaviruses", section on 'Respiratory syndromes'</a> and  <a class="medical medical_review" href="/z/d/html/3027.html" rel="external">"Severe acute respiratory syndrome (SARS)", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/106589.html" rel="external">"Middle East respiratory syndrome coronavirus: Clinical manifestations and diagnosis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/127488.html" rel="external">"COVID-19: Clinical manifestations and diagnosis in children"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rhinovirus has been implicated as a cause of pneumonia using PCR assays on specimens from the upper respiratory tract [<a href="#rid50">50,51</a>], but its etiologic role is questioned [<a href="#rid6">6,41,42,52,53</a>], especially in children younger than five years [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Human bocavirus and human parechovirus types 1, 2, and 3 also have been implicated as causes of LRTIs in children [<a href="#rid54">54-57</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bacteria – Important bacterial causes of pneumonia in preschool children include <em>S</em>. <em>pneumoniae</em>, <em>H</em>. <em>influenzae</em> type b (Hib), nontypeable <em>H</em>. <em>influenzae</em>, <em>Moraxella</em> <em>catarrhalis</em>, <em>S</em>. <em>aureus</em>, <em>S</em>. <em>pyogenes</em>, and atypical bacteria. <em>S</em>. <em>pneumoniae</em>, <em>S</em>. <em>aureus</em>, and <em>S</em>. <em>pyogenes</em> are associated with increased morbidity and mortality [<a href="#rid58">58-60</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>S</em>. <em>pneumoniae</em> is the most common typical bacterial pathogen causing pneumonia in all patients beyond the first few weeks after birth [<a href="#rid10">10,61</a>]. (See  <a class="medical medical_review" href="/z/d/html/6060.html" rel="external">"Pneumococcal pneumonia in children", section on 'Epidemiology'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hib is a rare cause of pneumonia in countries with universal childhood immunization.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>S</em>. <em>aureus</em> (particularly community-associated methicillin-resistant <em>S</em>. aureus [CA-MRSA]) and <em>S</em>. <em>pyogenes</em> are becoming increasingly frequent causes of CAP, particularly those complicated by necrosis and empyema [<a href="#rid58">58,62</a>]. In addition, these organisms occasionally cause pneumonia following influenza and chickenpox, respectively [<a href="#rid59">59,63</a>]. (See  <a class="medical medical_review" href="/z/d/html/6344.html" rel="external">"Epidemiology, clinical presentation, and evaluation of parapneumonic effusion and empyema in children"</a> and  <a class="medical medical_review" href="/z/d/html/8284.html" rel="external">"Clinical features of varicella-zoster virus infection: Chickenpox"</a>.)</p><p></p><p class="bulletIndent2">When associated with influenza, MRSA CAP can be particularly severe. (See  <a class="medical medical_review" href="/z/d/html/5973.html" rel="external">"Seasonal influenza in children: Clinical features and diagnosis", section on 'S. pneumoniae or S. aureus coinfection'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The prevalence of <em>M</em>. <em>pneumoniae</em> and <em>C</em>. <em>pneumoniae</em> may be increasing in preschool children with CAP [<a href="#rid64">64</a>]. (See  <a class="medical medical_review" href="/z/d/html/5957.html" rel="external">"Pneumonia caused by <i>Chlamydia pneumoniae</i> in children"</a> and  <a class="medical medical_review" href="/z/d/html/6070.html" rel="external">"<i>Mycoplasma pneumoniae</i> infection in children", section on 'Epidemiology'</a>.)</p><p></p><p class="headingAnchor" id="H20"><span class="h3">In children ≥5 years</span></p><p class="bulletIndent1"><span class="glyph">●</span><em>S</em>. <em>pneumoniae</em> is the most common typical bacterial cause of pneumonia in children older than five years (see  <a class="medical medical_review" href="/z/d/html/6060.html" rel="external">"Pneumococcal pneumonia in children", section on 'Epidemiology'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>M</em>. <em>pneumoniae</em> is more common among children ≥5 years than among younger children [<a href="#rid6">6,65</a>] (see  <a class="medical medical_review" href="/z/d/html/6070.html" rel="external">"<i>Mycoplasma pneumoniae</i> infection in children", section on 'Epidemiology'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>C</em>. <em>pneumoniae</em> also is emerging as a frequent cause of pneumonia in older children and young adults [<a href="#rid66">66</a>] (see  <a class="medical medical_review" href="/z/d/html/5957.html" rel="external">"Pneumonia caused by <i>Chlamydia pneumoniae</i> in children"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Although viruses primarily cause pneumonia in young children, the COVID-19 pandemic has demonstrated that SARS-CoV-2 can be responsible for severe pneumonia in older children/adolescents who have risk factors such as obesity (see  <a class="medical medical_review" href="/z/d/html/127488.html" rel="external">"COVID-19: Clinical manifestations and diagnosis in children"</a>)</p><p></p><p>In areas where CA-MRSA is prevalent, CA-MRSA is an important cause of CAP complicated by empyema and necrosis [<a href="#rid58">58,67</a>]. When associated with influenza, MRSA CAP can be particularly severe [<a href="#rid59">59,63</a>]. (See  <a class="medical medical_review" href="/z/d/html/6344.html" rel="external">"Epidemiology, clinical presentation, and evaluation of parapneumonic effusion and empyema in children"</a> and  <a class="medical medical_review" href="/z/d/html/6065.html" rel="external">"Methicillin-resistant <i>Staphylococcus aureus </i>infections in children: Epidemiology and clinical spectrum", section on 'Epidemiology and risk factors'</a>.)</p><p class="headingAnchor" id="H21"><span class="h2">Aspiration pneumonia</span><span class="headingEndMark"> — </span>When there is a predisposition to aspiration, pneumonia may be caused by anaerobic oral flora, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Anaerobic streptococci (eg, <em>Peptostreptococcus</em>)</p><p class="bulletIndent1"><span class="glyph">●</span><em>Fusobacterium</em> spp</p><p class="bulletIndent1"><span class="glyph">●</span><em>Bacteroides</em> spp</p><p class="bulletIndent1"><span class="glyph">●</span><em>Prevotella</em> <em>melaninogenica</em></p><p></p><p>Risk factors for aspiration include a history of seizure, anesthesia, or other episodes of reduced level of consciousness, neurologic disease, dysphagia, gastroesophageal reflux, alcohol or substance abuse, use of a nasogastric tube, or foreign body aspiration.</p><p class="headingAnchor" id="H22"><span class="h2">Hospital-acquired pneumonia</span><span class="headingEndMark"> — </span>Hospital-acquired pneumonia occurs ≥48 hours after admission and does not appear to be incubating at the time of admission. Hospital-acquired bacterial pneumonia is usually caused by gram-negative bacilli or <em>S</em>. <em>aureus</em>. Hospital-acquired pneumonia frequently occurs in intensive care units where mechanical ventilation, indwelling catheters, and administration of broad-spectrum antibiotics are common. (See  <a class="medical medical_review" href="/z/d/html/6054.html" rel="external">"Pneumonia in children: Inpatient treatment"</a>.)</p><p>In addition, during the winter respiratory viral season, hospitalized children are at risk for hospital-acquired pneumonia caused by RSV, parainfluenza, and influenza viruses. (See  <a class="medical medical_review" href="/z/d/html/5973.html" rel="external">"Seasonal influenza in children: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5975.html" rel="external">"Parainfluenza viruses in children", section on 'Clinical presentation'</a> and  <a class="medical medical_review" href="/z/d/html/5994.html" rel="external">"Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children", section on 'Transmission and incubation period'</a>.)</p><p class="headingAnchor" id="H23"><span class="h2">Special populations</span></p><p class="headingAnchor" id="H24"><span class="h3">Immunocompromised</span><span class="headingEndMark"> — </span>The causes of pneumonia in immunocompromised hosts include all of the pathogens mentioned above, as well as a variety of other organisms, as discussed below.</p><p>Gram-negative bacilli and <em>S</em>. <em>aureus</em> are common etiologies in neutropenic patients or in those with white blood cell defects. Clinically significant legionellosis usually is seen only in immunocompromised hosts with an exposure to an aquatic reservoir of <em>Legionella</em> <em>pneumophila</em>, such as a river, lake, air-conditioning cooling tower, or water distribution systems [<a href="#rid68">68,69</a>]. However, seroepidemiologic studies suggest that subclinical or minor infections occur in children [<a href="#rid70">70,71</a>]. (See  <a class="medical medical_review" href="/z/d/html/7029.html" rel="external">"Microbiology, epidemiology, and pathogenesis of <i>Legionella </i>infection"</a>.)</p><p>Opportunistic fungi, such as <em>Aspergillus</em> spp, <em>Mucoraceae</em> spp, and <em>Fusarium</em> spp, also are a concern in neutropenic patients and in those receiving immunosuppressive therapies that impair the cell-mediated response. One of the more common pneumonia pathogens diagnosed in human immunodeficiency virus (HIV)-infected patients is <em>Pneumocystis</em> <em>jirovecii</em>, which was formerly called <em>Pneumocystis</em> <em>carinii</em> [<a href="#rid72">72</a>]. (See  <a class="medical medical_review" href="/z/d/html/2454.html" rel="external">"Epidemiology and clinical manifestations of invasive aspergillosis"</a> and  <a class="medical medical_review" href="/z/d/html/2426.html" rel="external">"Mycology, pathogenesis, and epidemiology of Fusarium infection"</a> and  <a class="medical medical_review" href="/z/d/html/5963.html" rel="external">"Pediatric HIV infection: Classification, clinical manifestations, and outcome", section on 'Pneumocystis jirovecii pneumonia'</a>.)</p><p>Viral causes of pneumonia, which may be life-threatening in the immunocompromised host, including the post-solid organ and stem cell transplant populations, include:</p><p class="bulletIndent1"><span class="glyph">●</span>Common community-acquired viral agents such as [<a href="#rid73">73,74</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>RSV (see  <a class="medical medical_review" href="/z/d/html/5994.html" rel="external">"Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Adenovirus (see  <a class="medical medical_review" href="/z/d/html/8339.html" rel="external">"Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Influenza (see  <a class="medical medical_review" href="/z/d/html/5973.html" rel="external">"Seasonal influenza in children: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Parainfluenza (see  <a class="medical medical_review" href="/z/d/html/5975.html" rel="external">"Parainfluenza viruses in children", section on 'Risk and protective factors'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rhinovirus (see  <a class="medical medical_review" href="/z/d/html/8335.html" rel="external">"Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Human metapneumovirus (see  <a class="medical medical_review" href="/z/d/html/8311.html" rel="external">"Human metapneumovirus infections"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>SARS-CoV-2. (See  <a class="medical medical_review" href="/z/d/html/127488.html" rel="external">"COVID-19: Clinical manifestations and diagnosis in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rubeola (Hecht giant-cell pneumonia). (See  <a class="medical medical_review" href="/z/d/html/3021.html" rel="external">"Measles: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Immunocompromised patients'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Varicella-zoster virus (VZV). (See  <a class="medical medical_review" href="/z/d/html/8284.html" rel="external">"Clinical features of varicella-zoster virus infection: Chickenpox", section on 'Pneumonia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CMV. (See  <a class="medical medical_review" href="/z/d/html/5965.html" rel="external">"Overview of cytomegalovirus infections in children", section on 'Immunocompromised hosts'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Epstein-Barr virus, which may be the trigger for lymphoid interstitial pneumonitis (LIP), an indolent but progressive process that occurs in children infected with HIV. LIP can also be seen in patients with common variable immunodeficiency. (See  <a class="medical medical_review" href="/z/d/html/8283.html" rel="external">"Clinical manifestations and treatment of Epstein-Barr virus infection"</a> and  <a class="medical medical_review" href="/z/d/html/6381.html" rel="external">"Classification of diffuse lung disease (interstitial lung disease) in infants and children", section on 'Disorders of the immunocompromised host'</a>.)</p><p></p><p class="headingAnchor" id="H25"><span class="h3">Cystic fibrosis</span><span class="headingEndMark"> — </span>Young children with cystic fibrosis frequently are infected with <em>S</em>. <em>aureus</em>, <em>Pseudomonas</em> <em>aeruginosa</em>, and <em>H</em>. <em>influenzae</em> (mostly nontypeable strains). Later in the course of the disease, multiple drug-resistant gram-negative organisms, such as <em>Burkholderia</em> <em>cepacia</em>, <em>Stenotrophomonas</em> <em>maltophilia</em>, and <em>Achromobacter</em> <em>xylosoxidans</em>, can be recovered. <em>Aspergillus</em> spp and nontuberculous mycobacteria also may cause disease in this population. Cystic fibrosis lung disease is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6369.html" rel="external">"Cystic fibrosis: Clinical manifestations of pulmonary disease"</a> and  <a class="medical medical_review" href="/z/d/html/6372.html" rel="external">"Cystic fibrosis: Overview of the treatment of lung disease"</a> and  <a class="medical medical_review" href="/z/d/html/6371.html" rel="external">"Cystic fibrosis: Antibiotic therapy for chronic pulmonary infection"</a>.)</p><p class="headingAnchor" id="H26"><span class="h3">Sickle cell disease</span><span class="headingEndMark"> — </span>The prevalence of pneumonia is increased in children with sickle cell disease [<a href="#rid75">75</a>]. Atypical bacterial pathogens (eg, <em>M</em>. <em>pneumoniae</em>, <em>C</em>. <em>pneumoniae</em>) appear to be most frequent and are more commonly associated with the acute chest syndrome. Other bacterial causes of pneumonia in children with sickle cell disease include <em>S</em>. <em>pneumoniae</em>, <em>S</em>. <em>aureus</em>, and <em>H</em>. <em>influenzae</em> [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/z/d/html/16353.html" rel="external">"Acute chest syndrome (ACS) in sickle cell disease (adults and children)", section on 'Common triggers'</a>.)</p><p class="headingAnchor" id="H27"><span class="h2">Environmental considerations</span></p><p class="headingAnchor" id="H28"><span class="h3">Geography</span><span class="headingEndMark"> — </span>Residence in or travel to specific geographic areas should suggest endemic pathogens:</p><p class="bulletIndent1"><span class="glyph">●</span>Tuberculosis is most common in immigrants from countries with a high prevalence of infection (eg, countries throughout Asia, Africa, Latin America, and eastern Europe)  (<a class="graphic graphic_figure graphicRef55097" href="/z/d/graphic/55097.html" rel="external">figure 2</a>). (See  <a class="medical medical_review" href="/z/d/html/8018.html" rel="external">"Epidemiology of tuberculosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Measles pneumonia is common in the resource-limited countries. (See  <a class="medical medical_review" href="/z/d/html/3021.html" rel="external">"Measles: Clinical manifestations, diagnosis, treatment, and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Coccidioides</em> <em>immitis</em> is endemic to the southwestern United States, northern Mexico, and parts of Central and South America. (See  <a class="medical medical_review" href="/z/d/html/2460.html" rel="external">"Primary pulmonary coccidioidal infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Blastomyces</em> <em>dermatitidis</em>, causing blastomycosis, is endemic in the southeastern and central United States and the midwestern states bordering the Great Lakes. (See  <a class="medical medical_review" href="/z/d/html/2458.html" rel="external">"Mycology, pathogenesis, and epidemiology of blastomycosis"</a> and  <a class="medical medical_review" href="/z/d/html/2463.html" rel="external">"Treatment of blastomycosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the United States, <em>Histoplasma</em> <em>capsulatum</em> is most common in the Ohio, Mississippi, and Missouri River valleys but has been identified in all regions [<a href="#rid76">76,77</a>]. It also occurs in Canada, Central America, eastern and southern Europe, parts of Africa, eastern Asia, and Australia.</p><p></p><p class="bulletIndent1">Activities potentially leading to exposure to bird droppings and bat guano may be suggestive [<a href="#rid78">78</a>]. These include gardening, construction, cleaning of barns and outbuildings, and spelunking. (See  <a class="medical medical_review" href="/z/d/html/2450.html" rel="external">"Pathogenesis and clinical features of pulmonary histoplasmosis"</a> and  <a class="medical medical_review" href="/z/d/html/2451.html" rel="external">"Diagnosis and treatment of pulmonary histoplasmosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the United States, hantavirus cardiopulmonary syndrome (acute febrile illness associated with respiratory failure, shock, and high mortality) occurs predominantly west of the Mississippi River (in the "four corners" region of the United States where the borders of Colorado, New Mexico, Arizona, and Utah meet) after environmental exposure to infected deer mouse (<em>Peromyscus</em> <em>maniculatus</em>) saliva, urine, or feces. Activities associated with exposure include cleaning of barns and outbuildings, trapping rodents, animal herding, and farming with hand tools. (See  <a class="medical medical_review" href="/z/d/html/8307.html" rel="external">"Epidemiology and diagnosis of hantavirus infections"</a> and  <a class="medical medical_review" href="/z/d/html/8321.html" rel="external">"Hantavirus cardiopulmonary syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>MERS is endemic in countries in or near the Arabian Peninsula. (See  <a class="medical medical_review" href="/z/d/html/89705.html" rel="external">"Middle East respiratory syndrome coronavirus: Virology, pathogenesis, and epidemiology"</a> and  <a class="medical medical_review" href="/z/d/html/106589.html" rel="external">"Middle East respiratory syndrome coronavirus: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H29"><span class="h3">Animal exposures</span><span class="headingEndMark"> — </span>Histoplasmosis is associated with exposure to bird droppings and bat guano, and hantavirus infection is associated with exposure to an infected deer mouse. Other causes of pneumonia that are associated with animal exposure include:</p><p class="bulletIndent1"><span class="glyph">●</span><em>Chlamydia</em> <em>psittaci</em> (psittacosis), which is transmitted to humans predominantly from domestic and wild birds. (See  <a class="medical medical_review" href="/z/d/html/7015.html" rel="external">"Psittacosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Coxiella</em> <em>burnetii</em> (Q fever), which is associated with exposure to parturient sheep, goats, cattle, and cats (or exposure to dust/soil contaminated by these animals). Additional information about Q fever is available on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fqfever%2Fhealthcare-providers%2Findex.html&amp;token=JesNUNaJCNOJVQWCCy%2BywE9kqc5IU385wxveHccQyRSfy2l%2Fi1Nn583eHrl95FWC%2BYgb2SZ9DkIEVM4LBxkNAg%3D%3D&amp;TOPIC_ID=5979" target="_blank">United Stated Centers for Disease Control and Prevention website</a> [<a href="#rid79">79,80</a>].</p><p></p><p class="headingAnchor" id="H30"><span class="h3">Other exposures</span><span class="headingEndMark"> — </span>Exposure to individuals at high risk for tuberculosis is a risk factor for the development of tuberculosis in children. High-risk individuals include people experiencing homelessness, recent immigrants from endemic regions  (<a class="graphic graphic_figure graphicRef55097" href="/z/d/graphic/55097.html" rel="external">figure 2</a>), incarcerated individuals, and HIV-infected patients. (See  <a class="medical medical_review" href="/z/d/html/8018.html" rel="external">"Epidemiology of tuberculosis"</a>.)</p><p class="headingAnchor" id="H3706576257"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110776.html" rel="external">"Society guideline links: Pediatric pneumonia"</a>.)</p><p class="headingAnchor" id="H8576810"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/17120.html" rel="external">"Patient education: Pneumonia in children (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H31"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Pneumonia is more common in children younger than five years of age than in older children and adolescents. Risk factors for pneumonia include environmental crowding, having school-age siblings, and underlying cardiopulmonary and other medical disorders. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – Pneumonia can be caused by a large number of microorganisms  (<a class="graphic graphic_table graphicRef54228 graphicRef71263" href="/z/d/graphic/54228.html" rel="external">table 1A-B</a>). The agents commonly responsible vary according to the age of the child and the setting in which the infection is acquired. (See <a class="local">'Etiologic agents'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Community-acquired pneumonia</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Children &lt;5 years – Viruses are most common. However, bacterial pathogens, including <em>Streptococcus</em> <em>pneumoniae</em>, <em>Staphylococcus</em> <em>aureus</em>, and <em>Streptococcus</em> <em>pyogenes</em>, also are important. (See <a class="local">'In children &lt;5 years'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Otherwise healthy children ≥5 years – <em>S</em>. <em>pneumoniae</em>, <em>Mycoplasma</em> <em>pneumoniae</em>, and <em>Chlamydia</em> <em>pneumoniae</em> are most common. (See <a class="local">'In children ≥5 years'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Children of all ages – Community-associated methicillin-resistant <em>S</em>. <em>aureus</em> is an increasingly important pathogen.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Necrotizing pneumonia – Common causes of necrotizing pneumonia include <em>S</em>. <em>pneumoniae</em>, <em>S</em>. <em>aureus</em>, and <em>S</em>. <em>pyogenes</em>. (See <a class="local">'Pathologic patterns of pneumonia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aspiration pneumonia – Aspiration pneumonia is usually caused by anaerobic oral flora. (See <a class="local">'Aspiration pneumonia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hospital-acquired pneumonia – Hospital-acquired pneumonia is usually caused by gram-negative bacilli or <em>S</em>. <em>aureus</em>. (See <a class="local">'Hospital-acquired pneumonia'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011; 66 Suppl 2:ii1.</a></li><li><a class="nounderline abstract_t">McAllister DA, Liu L, Shi T, et al. Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health 2019; 7:e47.</a></li><li><a class="nounderline abstract_t">Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58:1.</a></li><li><a class="nounderline abstract_t">Griffin MR, Mitchel E, Moore MR, et al. Declines in pneumonia hospitalizations of children aged &lt;2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012. MMWR Morb Mortal Wkly Rep 2014; 63:995.</a></li><li><a class="nounderline abstract_t">Global Burden of Disease Child and Adolescent Health Collaboration, Kassebaum N, Kyu HH, et al. Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study. JAMA Pediatr 2017; 171:573.</a></li><li><a class="nounderline abstract_t">Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015; 372:835.</a></li><li><a class="nounderline abstract_t">Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of Respiratory Viral Infections. Annu Rev Virol 2020; 7:83.</a></li><li><a class="nounderline abstract_t">Glezen P, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973; 288:498.</a></li><li><a class="nounderline abstract_t">Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol 1993; 137:977.</a></li><li><a class="nounderline abstract_t">Pelton SI, Hammerschlag MR. Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children. Clin Pediatr (Phila) 2005; 44:1.</a></li><li><a class="nounderline abstract_t">Green GM, Carolin D. The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages. N Engl J Med 1967; 276:421.</a></li><li><a class="nounderline abstract_t">MacGregor RR. Alcohol and immune defense. JAMA 1986; 256:1474.</a></li><li><a class="nounderline abstract_t">Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004; 113:443.</a></li><li><a class="nounderline abstract_t">Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369:1179.</a></li><li><a class="nounderline abstract_t">Griffin MR, Zhu Y, Moore MR, et al. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369:155.</a></li><li><a class="nounderline abstract_t">Olarte L, Barson WJ, Barson RM, et al. Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clin Infect Dis 2017; 64:1699.</a></li><li><a class="nounderline abstract_t">Alicino C, Paganino C, Orsi A, et al. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis. Vaccine 2017; 35:5776.</a></li><li><a class="nounderline abstract_t">Madhi SA, Klugman KP, Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004; 10:811.</a></li><li><a class="nounderline abstract_t">Margolis P, Gadomski A. The rational clinical examination. Does this infant have pneumonia? JAMA 1998; 279:308.</a></li><li class="breakAll">Mani CS. Acute pneumonia and its complications. In: Principles and Practice of Pediatric Infectious Diseases, 5th ed, Long SS, Prober CG, Fischer M (Eds), Elsevier, Philadelphia 2018. p.238.</li><li><a class="nounderline abstract_t">Aherne W, Bird T, Court SD, et al. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970; 23:7.</a></li><li><a class="nounderline abstract_t">Lemaître C, Angoulvant F, Gabor F, et al. Necrotizing pneumonia in children: report of 41 cases between 2006 and 2011 in a French tertiary care center. Pediatr Infect Dis J 2013; 32:1146.</a></li><li class="breakAll">Baltimore RS. Pneumonia. In: Pediatric Infectious Diseases: Principles and Practice, 2nd ed, Jenson HB, Baltimore RS (Eds), WB Saunders, Philadelphia 2002. p.794.</li><li class="breakAll">Shah SS, Bradley JS. Pediatric community-acquired pneumonia. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison G, Kaplan SL, et al (Eds), Elsevier, Philadelphia 2018. p.208.</li><li><a class="nounderline abstract_t">Dakhama A, Lee YM, Gelfand EW. Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr Infect Dis J 2005; 24:S159.</a></li><li><a class="nounderline abstract_t">Isaacs D. Problems in determining the etiology of community-acquired childhood pneumonia. Pediatr Infect Dis J 1989; 8:143.</a></li><li><a class="nounderline abstract_t">Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999; 18:98.</a></li><li><a class="nounderline abstract_t">Korppi M, Heiskanen-Kosma T, Jalonen E, et al. Aetiology of community-acquired pneumonia in children treated in hospital. Eur J Pediatr 1993; 152:24.</a></li><li><a class="nounderline abstract_t">Claesson BA, Trollfors B, Brolin I, et al. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J 1989; 8:856.</a></li><li><a class="nounderline abstract_t">Ruuskanen O, Nohynek H, Ziegler T, et al. Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis 1992; 11:217.</a></li><li><a class="nounderline abstract_t">Gendrel D, Raymond J, Moulin F, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis 1997; 16:388.</a></li><li><a class="nounderline abstract_t">Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 1998; 17:986.</a></li><li><a class="nounderline abstract_t">Numazaki K, Chiba S, Umetsu M, et al. Etiological agents of lower respiratory tract infections in Japanese children. In Vivo 2004; 18:67.</a></li><li><a class="nounderline abstract_t">Turner RB, Lande AE, Chase P, et al. Pneumonia in pediatric outpatients: cause and clinical manifestations. J Pediatr 1987; 111:194.</a></li><li><a class="nounderline abstract_t">Vuori E, Peltola H, Kallio MJ, et al. Etiology of pneumonia and other common childhood infections requiring hospitalization and parenteral antimicrobial therapy. SE-TU Study Group. Clin Infect Dis 1998; 27:566.</a></li><li><a class="nounderline abstract_t">Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113:701.</a></li><li><a class="nounderline abstract_t">Cevey-Macherel M, Galetto-Lacour A, Gervaix A, et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr 2009; 168:1429.</a></li><li><a class="nounderline abstract_t">Nolan VG, Arnold SR, Bramley AM, et al. Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia. J Infect Dis 2018; 218:179.</a></li><li><a class="nounderline abstract_t">Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet 2019; 394:757.</a></li><li><a class="nounderline abstract_t">Rima B, Collins P, Easton A, et al. ICTV Virus Taxonomy Profile: Pneumoviridae. J Gen Virol 2017; 98:2912.</a></li><li><a class="nounderline abstract_t">Rhedin S, Lindstrand A, Hjelmgren A, et al. Respiratory viruses associated with community-acquired pneumonia in children: matched case-control study. Thorax 2015; 70:847.</a></li><li><a class="nounderline abstract_t">Self WH, Williams DJ, Zhu Y, et al. Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. J Infect Dis 2016; 213:584.</a></li><li class="breakAll">Chen TK, Cherry JD. Adenoviruses. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison G, Kaplan SL, et al (Eds), Elsevier, Philadelphia 2018. p.1364.</li><li><a class="nounderline abstract_t">Orvedahl A, Padhye A, Barton K, et al. Clinical Characterization of Children Presenting to the Hospital with Enterovirus D68 Infection During the 2014 Outbreak in St. Louis. Pediatr Infect Dis J 2016; 35:481.</a></li><li><a class="nounderline abstract_t">Bosis S, Esposito S. Enterovirus D68-Associated Community-Acquired Pneumonia in the Pediatric Age Group. Curr Infect Dis Rep 2017; 19:12.</a></li><li><a class="nounderline abstract_t">Heugel J, Martin ET, Kuypers J, Englund JA. Coronavirus-associated pneumonia in previously healthy children. Pediatr Infect Dis J 2007; 26:753.</a></li><li><a class="nounderline abstract_t">Memish ZA, Al-Tawfiq JA, Assiri A, et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J 2014; 33:904.</a></li><li><a class="nounderline abstract_t">Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics 2020; 145.</a></li><li><a class="nounderline abstract_t">Kahn JS, McIntosh K. History and recent advances in coronavirus discovery. Pediatr Infect Dis J 2005; 24:S223.</a></li><li><a class="nounderline abstract_t">Juvén T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000; 19:293.</a></li><li><a class="nounderline abstract_t">Lu X, Schneider E, Jain S, et al. Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia. J Infect Dis 2017; 216:1104.</a></li><li><a class="nounderline abstract_t">Spichak TV, Yatsyshina SB, Кatosova LК, et al. Is the role of rhinoviruses as causative agents of pediatric community-acquired pneumonia over-estimated? Eur J Pediatr 2016; 175:1951.</a></li><li><a class="nounderline abstract_t">Shi T, McLean K, Campbell H, Nair H. Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta-analysis. J Glob Health 2015; 5:010408.</a></li><li><a class="nounderline abstract_t">Longtin J, Bastien M, Gilca R, et al. Human bocavirus infections in hospitalized children and adults. Emerg Infect Dis 2008; 14:217.</a></li><li><a class="nounderline abstract_t">Abed Y, Boivin G. Human parechovirus types 1, 2 and 3 infections in Canada. Emerg Infect Dis 2006; 12:969.</a></li><li><a class="nounderline abstract_t">Don M, Söderlund-Venermo M, Valent F, et al. Serologically verified human bocavirus pneumonia in children. Pediatr Pulmonol 2010; 45:120.</a></li><li><a class="nounderline abstract_t">Schlaberg R, Ampofo K, Tardif KD, et al. Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia. J Infect Dis 2017; 216:688.</a></li><li><a class="nounderline abstract_t">Schwartz KL, Nourse C. Panton-Valentine leukocidin-associated Staphylococcus aureus necrotizing pneumonia in infants: a report of four cases and review of the literature. Eur J Pediatr 2012; 171:711.</a></li><li><a class="nounderline abstract_t">Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006; 12:894.</a></li><li class="breakAll">Miller MA, Ben-Ami T, Daum RS. Bacterial pneumonia in neonates and older children. In: Pediatric Respiratory Medicine, Taussig LM, Landau LI (Eds), Mosby, St. Louis 1999. p.595.</li><li><a class="nounderline abstract_t">Heiskanen-Kosma T, Korppi M, Leinonen M. Serologically indicated pneumococcal pneumonia in children: a population-based study in primary care settings. APMIS 2003; 111:945.</a></li><li><a class="nounderline abstract_t">Al-Kaabi N, Solh Z, Pacheco S, et al. A Comparison of group A Streptococcus versus Streptococcus pneumoniae pneumonia. Pediatr Infect Dis J 2006; 25:1008.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325.</a></li><li><a class="nounderline abstract_t">Esposito S, Bosis S, Cavagna R, et al. Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis 2002; 35:1345.</a></li><li><a class="nounderline abstract_t">Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 2004; 9:109.</a></li><li><a class="nounderline abstract_t">Kurz H, Göpfrich H, Wabnegger L, Apfalter P. Role of Chlamydophila pneumoniae in children hospitalized for community-acquired pneumonia in Vienna, Austria. Pediatr Pulmonol 2009; 44:873.</a></li><li><a class="nounderline abstract_t">Carrillo-Marquez MA, Hulten KG, Hammerman W, et al. Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital. Pediatr Infect Dis J 2011; 30:545.</a></li><li><a class="nounderline abstract_t">Greenberg D, Chiou CC, Famigilleti R, et al. Problem pathogens: paediatric legionellosis--implications for improved diagnosis. Lancet Infect Dis 2006; 6:529.</a></li><li><a class="nounderline abstract_t">Cunha BA, Burillo A, Bouza E. Legionnaires' disease. Lancet 2016; 387:376.</a></li><li><a class="nounderline abstract_t">Muldoon RL, Jaecker DL, Kiefer HK. Legionnaires' disease in children. Pediatrics 1981; 67:329.</a></li><li><a class="nounderline abstract_t">Andersen RD, Lauer BA, Fraser DW, et al. Infections with Legionella pneumophila in children. J Infect Dis 1981; 143:386.</a></li><li><a class="nounderline abstract_t">Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002; 8:891.</a></li><li><a class="nounderline abstract_t">Lo MS, Lee GM, Gunawardane N, et al. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplant 2013; 17:133.</a></li><li><a class="nounderline abstract_t">Arslan D, Danziger-Isakov L. Respiratory viral infections in pediatric solid organ and hematopoietic stem cell transplantation. Curr Infect Dis Rep 2012; 14:658.</a></li><li><a class="nounderline abstract_t">De Ceulaer K, McMullen KW, Maude GH, et al. Pneumonia in young children with homozygous sickle cell disease: risk and clinical features. Eur J Pediatr 1985; 144:255.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention. Histoplasmosis in a state where it is not known to be endemic--Montana, 2012-2013. MMWR Morb Mortal Wkly Rep 2013; 62:834.</a></li><li><a class="nounderline abstract_t">Benedict K, Beer KD, Jackson BR. Histoplasmosis-related Healthcare Use, Diagnosis, and Treatment in a Commercially Insured Population, United States. Clin Infect Dis 2020; 70:1003.</a></li><li><a class="nounderline abstract_t">Ouellette CP, Stanek JR, Leber A, Ardura MI. Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis. J Pediatric Infect Dis Soc 2019; 8:400.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Q fever: Information for Healthcare Providers. https://www.cdc.gov/qfever/healthcare-providers/index.html (Accessed on December 09, 2022).</li><li><a class="nounderline abstract_t">Anderson A, Bijlmer H, Fournier PE, et al. Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep 2013; 62:1.</a></li></ol></div><div id="topicVersionRevision">Topic 5979 Version 52.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21903691" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30497986" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19644442" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25375070" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Declines in pneumonia hospitalizations of children aged&lt;2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28384795" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25714161" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Community-acquired pneumonia requiring hospitalization among U.S. children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32196426" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Seasonality of Respiratory Viral Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4346164" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Epidemiology of acute lower respiratory disease in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8317455" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15678226" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6019163" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3747066" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Alcohol and immune defense.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14993532" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17416262" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23841730" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28199482" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28911902" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15247911" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A role for Streptococcus pneumoniae in virus-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9450716" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The rational clinical examination. Does this infant have pneumonia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9450716" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The rational clinical examination. Does this infant have pneumonia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4909103" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Pathological changes in virus infections of the lower respiratory tract in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23722529" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Necrotizing pneumonia in children: report of 41 cases between 2006 and 2011 in a French tertiary care center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23722529" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Necrotizing pneumonia in children: report of 41 cases between 2006 and 2011 in a French tertiary care center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23722529" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Necrotizing pneumonia in children: report of 41 cases between 2006 and 2011 in a French tertiary care center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16378041" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Virus-induced airway dysfunction: pathogenesis and biomechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2785261" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Problems in determining the etiology of community-acquired childhood pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10048679" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Etiology and treatment of community-acquired pneumonia in ambulatory children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8444202" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Aetiology of community-acquired pneumonia in children treated in hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2516622" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1597197" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pneumonia in childhood: etiology and response to antimicrobial therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9228482" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Etiology and response to antibiotic therapy of community-acquired pneumonia in French children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9849979" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Etiology of childhood pneumonia: serologic results of a prospective, population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15011754" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Etiological agents of lower respiratory tract infections in Japanese children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3612389" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Pneumonia in pediatric outpatients: cause and clinical manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9770158" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Etiology of pneumonia and other common childhood infections requiring hospitalization and parenteral antimicrobial therapy. SE-TU Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15060215" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19238436" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29228381" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31257127" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29087278" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : ICTV Virus Taxonomy Profile: Pneumoviridae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26077969" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Respiratory viruses associated with community-acquired pneumonia in children: matched case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26180044" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26180044" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26771663" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Clinical Characterization of Children Presenting to the Hospital with Enterovirus D68 Infection During the 2014 Outbreak in St. Louis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28251508" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Enterovirus D68-Associated Community-Acquired Pneumonia in the Pediatric Age Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17848893" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Coronavirus-associated pneumonia in previously healthy children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24763193" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Middle East respiratory syndrome coronavirus disease in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32179660" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Epidemiology of COVID-19 Among Children in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16378050" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : History and recent advances in coronavirus discovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10783017" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Etiology of community-acquired pneumonia in 254 hospitalized children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28968668" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27714467" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Is the role of rhinoviruses as causative agents of pediatric community-acquired pneumonia over-estimated?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26445672" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18258113" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Human bocavirus infections in hospitalized children and adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16707054" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Human parechovirus types 1, 2 and 3 infections in Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19960524" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Serologically verified human bocavirus pneumonia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28934425" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22159957" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Panton-Valentine leukocidin-associated Staphylococcus aureus necrotizing pneumonia in infants: a report of four cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16707043" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16707043" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14616546" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Serologically indicated pneumococcal pneumonia in children: a population-based study in primary care settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17072122" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : A Comparison of group A Streptococcus versus Streptococcus pneumoniae pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17431376" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12439797" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14982611" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19670403" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Role of Chlamydophila pneumoniae in children hospitalized for community-acquired pneumonia in Vienna, Austria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21407143" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16870531" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Problem pathogens: paediatric legionellosis--implications for improved diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26231463" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Legionnaires' disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7017574" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Legionnaires' disease in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7229438" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Infections with Legionella pneumophila in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12194762" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : A new name (Pneumocystis jiroveci) for Pneumocystis from humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23228170" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22968439" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Respiratory viral infections in pediatric solid organ and hematopoietic stem cell transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4054164" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Pneumonia in young children with homozygous sickle cell disease: risk and clinical features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24153314" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Histoplasmosis in a state where it is not known to be endemic--Montana, 2012-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31037290" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Histoplasmosis-related Healthcare Use, Diagnosis, and Treatment in a Commercially Insured Population, United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30124985" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30124985" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23535757" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
